BRUSSELS LAUNCHES ANTI-TRUST PROBE ON JOHNSON & JOHNSON AND NOVARTIS
November 1st, 2011
BY KEITH NUTHALL
THE EUROPEAN Commission has launched a detailed anti-trust investigation into concerns that US-based Johnson & Johnson may have paid the generic branches of Switzerland's Novartis to hinder the sale of generic versions of pain killer Fentanyl in the Netherlands. A European Commission communique said this delay could have been caused by "contractual arrangements" between the two companies. If the Commission concludes these break European Union (EU) anti-trust laws, it could impose huge fines. EU competition Commissioner Joaquín ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.